Table 10.
Table 10. Clinical Management of Common Treatment-Emergent Adverse Events Associated With Proteasome Inhibitors and Immunomodulatory Agents Used in the Treatment of Multiple Myeloma
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.